This was the stock's third consecutive day of losses.
US biopharmaceuticals giant Gilead has thrown its weight behind a potential merger of Ireland’s Poolbeg Pharma and Austria ...
The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...
Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $1,101.15 today based on a ...
Here are some highlights from around the Marion area with boys winter sports teams and athletes who competed over the New ...
A plan by Poolbeg Pharma, the clinical-stage biopharmaceutical company led by serial entrepreneur Cathal Friel, to merge with ...
A Dublin-based comedian is hoping to raise awareness around speech impediments by bringing a movie about stammering to the ...
In the first game of the William & Marjorie Grover Holiday Classic hosted by Pleasant, Avah Steele earned a milestone for the ...
The conversation, as usual, had split opinions, with some calling career goals a scam and others agreeing that they’d love an ...
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...
A decrease in California's sexually transmitted infections (STIs) followed early real-world adoption of doxycycline ...
The landscape of pandemic response has been transformed, with new standards being set for clinical excellence. A new report looks at emerging therapies, trial insights, and the innovations shaping the ...